
So his explanation that evolution doesn't occur is by admitting that bacteria evolves and evolves new functionality that it didn't not have before.kleinman said:17.) nylon-eating bacteria-a polymerase evolves into a polymerase, what’s your point?
17.) nylon-eating bacteria-a polymerase evolves into a polymerase, what’s your point?
Yeah, I hope Dr. A gets a load of that one.Did he just say it "evolves" ? I thought that was mathematically and empirically impossible !
Kleinman is merely operating as a troll at this point, using the tried and true method of maintaining a debate without any substantive argument:Did he just say it "evolves" ? I thought that was mathematically and empirically impossible !
I know I am going to regret posting in this thread. And no, I have not read all 7900 (and counting) posts in it. My apoligies if this has already been discussed. How could it not be after this many posts?![]()
If I recall some of this thread and understood the arguments, one of Kleinman's arguments is that multiple selection pressures cause would cause evolution to slow such that what we observe today could not have evolved in the time given.
1) There was a recent article noting that fishery policies of catch size restrictions (size of the individual fish, not the size/volume of total catch) have caused an observed accelleration of fish evolution. Specifically, the species are coming to sexual maturity faster and not growing as large. A new selection pressure (size selection during "predation") has resulted in an observable accelleration.
2) When is there ever only one selection pressure? Just thinking about the fish example, there are always many pressures. Preators that eat eggs, predators that eat fry, predators that eat large fish, predators that pick a specific size of fish (see #1), availability/seasonailty of food, changes in food types, bacteria, virii, changes in water temperature/sailnity/clarity/pollutants/depth/availability, AND CONSTANT CHANGES TO THE INTENSITY OF EACH OF THESE PRESSURES. And yet we observe evolutionary changes.
It took me less than a minute to think of all items in this list. There must be more.
We now return you to your strawman burning already in progress.
CT
Yes, you do find it worthwhile.I think it worthwhile ...
<1500 words of kleinmania deleted for pointlessness>
Facilitating the evolution of resistance to avian malaria[/SIZE][/FONT] [FONT=Times New Roman][SIZE=3]in Hawaiian birds said:In some cases it is the combination of multiple stressors that lead to the decline of species or groups of species; e.g., amphibians by nematodes (Johnson et al., 1999), increased UV radiation and pollutants (Hatch and Blaustein, 2003; Beebee and Griffiths, 2005), and disease (Collins and Storfer, 2003; Daszak et al., 2003). Conserving endangered species and facilitating their recovery is one the main environmental challenges of the 21st century. Unfortunately, history has shown that in most cases permanent removal of stressors has not been possible and species often need to be
Facilitating the evolution of resistance to avian malaria[/SIZE][/FONT] [FONT=Times New Roman][SIZE=3]in Hawaiian birds said:managed indefinitely to ensure their persistence; of the 1263 species listed under the Endangered Species Act of the United States less than 2% have been de-listed (US Fish and Wildlfe Service, 2004).
Do you [Kleinman] even read other people's posts?
http://www.ajtmh.org/cgi/content/full/71/2_suppl/179Modelling the genetic basis of antiretroviral resistance said:The development of combination antiretroviral therapy was an immense breakthrough in HIV treatment, turning a previously lethal infection into a chronic treatable condition. In the absence of a vaccine, combination therapy is the only way HIV infection can be controlled, but there are two major problems, side effects due to toxicity and the development of resistance. Almost all drug failure is associated with antiretroviral resistance, which for some drugs (eg 3TC monotherapy) can arise within days (Frost et al. 2000). Combination therapy extends the period of efficacy greatly, but resistance still appears in a majority of patients.
How about this citation? You evolutionists think that recombination is the super mechanism which somehow transforms one species into another.ANTIMALARIAL DRUG RESISTANCE said:Increasing resistance of Plasmodium falciparum malaria to antimalarial drugs is posing a major threat to the global effort to "Roll Back Malaria". Chloroquine and sulfadoxine-pyrimethamine (SP) are being rendered increasingly ineffective, resulting in increasing morbidity, mortality, and economic and social costs. One strategy advocated for delaying the development of resistance to the remaining armory of effective drugs is the wide-scale deployment of artemisinin-based combination therapy. However, the cost of these combinations are higher than most of the currently used monotherapies and alternative non-artemisinin-based combinations.
andThe importance of the recombination of HI-viruses Often "wrongly" recombined said:The immune deficiency syndrome, AIDS is a huge health problem worldwide – and will remain so for some time to come. One reason lies in the HI-viruses' ability to become resistant to specific drugs. Until now, scientists have supposed that the recombination of different viruses plays an important role here. But researchers at ETH now show that the recombination can in fact slow down the build-up of resistance and that it advances it under certain specific conditions. This throws light on the question of why sexuality exists.
The importance of the recombination of HI-viruses Often "wrongly" recombined said:So what are the possible consequences of this model for the ETH research team? Sebastian Bonhoeffer points to two aspects, the first of which is medical. If gene variants that are antagonistic to one another exist, then the build-up of resistance to a combination of drugs that favours such genes would be slowed down by recombination. What is missing from the picture is information on how strongly certain mutations in the HIV genome act synergistically or antagonistically on one another. Bonhoeffer now wants to turn his attention to this question using HI-virus data sequences, which he has in abundance.
The importance of the recombination of HI-viruses Often "wrongly" recombined said:
However, such an analysis is not only relevant from a medical point of view. Bonhoeffer comes to his second point. It is highly possible that the results of such an investigation could also deliver insights into a far more fundamental question; why on earth does recombination exist? Because, as Bonhoeffer's model shows, in many cases this process has unfavourable consequences for HI-viruses. From an evolutionary point of view, it must be presumed that, under certain circumstances, the acquisition of recombination is advantageous. If these circumstances can be identified in the case of the HI-viruses then conclusions might be drawn on the reason – or reasons – for recombination in higher-order beings. Even though sexual reproduction and concomitant recombination is widespread, the advantages of sex as a means of reproduction is still one of biology's better kept secrets – despite numerous theories.
http://www.who.int/infectious-disease-report/2000/ch5.htmThe Role of Antiretrovirals and Drug Resistance in Vertical Transmission of HIV-1 Infection said:Large-cohort studies in North America, Europe, and Thailand have shown that zidovudine/azidothymidine (AZT) monotherapy, given at the late stages of pregnancy, is of proven benefit in reducing mother-to-infant HIV transmission by 51% to 68%. AZT monotherapy will not be of long-term benefit for mothers because no single drug can counteract viral infection; benefits to babies will be short-lived if HIV-1 is acquired through breastfeeding after birth. Unfortunately, ongoing mutation of HIV under conditions of drug pressure allows for the evolution and selection of AZT-resistant viruses. Emergence of AZT-resistant variants in pregnant mothers (7-29%) and their infected offspring (5-21%) has been described in several studies. Drug resistance arises more frequently in those mothers who received AZT therapy before pregnancy. Recent advances in combination chemotherapy may provide alternative strategies in prevention of vertical transmission and drug resistance. Genotypic screening of the HIV-1 isolated from pregnant mothers may provide rational modifications in antiretroviral (ARV) strategies to circumvent vertical HIV transmission. This may be of advantage for resource-rich nations but not for underdeveloped nations with limited access to ARVs. Public health programs are vital to have an impact on the tragic pandemic of pediatric AIDS.
AndCall to Action: A Massive Effort to Provide Proper Treatment said:Drug combinations have long been recognised as critical in combating multi drug-resistant malaria.
http://www.nyas.org/ebriefreps/main.asp?intSubsectionID=5103Call to Action: A Massive Effort to Provide Proper Treatment said:It wasn't until the 1950s that effective treatment for leprosy was introduced into vulnerable populations. By the 70s, the organism had launched a major counter-offensive and had effectively disarmed and rendered obsolete the sulpha drug dapsone. By the 1980s, two drugs – rifampicin and clofazamine – cleared the way for viable treatment alternatives. The organism developed resistance to all three drugs when prescribed singly but in combination with dapsone, these new medications effectively trounced the leprosy bacilli and led the way to cure and – researchers hope – elimination by 2005. Wiser for the experience, scientists are holding back three alternative drugs in the event that resistance recurs. The only outstanding issue however is cost. Fortunately, a solution involving the private and public sectors working in tandem with corporate interests means patients need wait no longer. Blister packs containing multi-drug therapies are now being distributed to patients free of charge. Thanks to WHO-sponsored research grants, Nippon Foundation funds, and donations of medication from the Swiss pharmaceutical Novartis, leprosy is on the way out.
andA New Approach to Fighting Malaria said:"In the history of malaria disease, we lost all the single drugs by drug resistance."
Now I know that there are evolutionists out there who have the ridiculous belief that variations in the weather like blizzards turn lizards into buzzards with gizzards and there are evolutionist mythematicians who believe that n+1 selection pressures cause a population to evolve more quickly than n selection pressures and this is good stuff for the SciFi channel but they simply do not have mathematical or empirical evidence of these ridiculous speculations. While on the other hand, we have posted and will continue to post the empirical evidence which substantiates the mathematics which show that combination selection pressures profoundly slow the mutation and selection sorting/optimization process.A New Approach to Fighting Malaria said:For example, the best current treatments for malaria are clearly artemisinin-based combination therapies, or ACTs, which were develop in the early 1990s. These drugs exploit the effectiveness of artemisinin, to which resistance has not yet developed, but combine it with older antibiotics to sustain this effectiveness.
ThenDr Schneider said:Mutate each creature by changing its genome randomly. For example, the program might change the letter at position 82 from an A to a T. Mutation happens everywhere in the genome, both in the gene, in the binding sites, and in the spaces between. The location is random and the change is random.
Dr Schneider said:Evaluate each creature: count the number of mistakes each one makes.
Dr Schneider said:This is the first step of selection.
Dr Schneider said:Sort the creatures by their mistakes.
Dr Schneider said:This is the second step of selection.
Dr Schneider said:Kill half of the creatures, the ones that make the most mistakes.
Dr Schneider said:This is the final step of selection.
ThenDr Schneider said:Replicate (make another copy of) the creatures that make the least mistakes.
Now, Dr Schneider has suggested the following in his publication on ev in Nucleic Acids Research http://nar.oxfordjournals.org/cgi/content/full/28/14/2794 .Dr Schneider said:The cycle is repeated every 'generation'.
When you actually do the bookkeeping associated with the mutation and selection sorting/optimization process that Dr Schneider has mathematically modeled, it shows that increasing population sizes have only a small affect on the rate of information accumulation, increasing genome length markedly slow the rate of information accumulation, number of sites has only a minimal affect on the rate of information accumulation, mutation rate has an approximately linear affect on the rate of information accumulation (for realistic mutation rates) however, the number of selection pressures has a profound affect on the rate of information accumulation. A single selection condition can be sorted for very rapidly by Dr Schneider’s sorting algorithm while all three selection conditions can only be sorted for rapidly only on extremely tiny unrealistic length genomes. This mathematical behavior that Dr Schneider’s mathematical model demonstrates is reflected in reality as demonstrated by more of these real examples of the mutation and selection sorting/optimization process.Evolution of Biological Information said:Variations of the program could be used to investigate how population size, genome length, number of sites, size of recognition regions, mutation rate, selective pressure, overlapping sites and other factors affect the evolution. Another use of the program may include understanding the sources and effects of skewed genomic composition (4,7,30,31). However, this could be caused by mutation rates, and/or it could be the result of some kind(s) of evolutionary pressure that we don’t understand, so how one implements the skew may well affect or bias the results.
andEffect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens said:Abacavir (ABC) selects for four mutations (K65R, L74V, Y115F and M184V) in HIV-1 reverse transcriptase (RT), both in vitro and during monotherapy in vivo. The aim of this analysis was to compare the selection of these and other nucleoside reverse transcriptase inhibitor (NRTI)-associated mutations by ABC-containing therapies in the presence and absence of concurrent lamivudine (3TC) and/or zidovudine (ZDV) and to assess the effect of these mutations on phenotypic susceptibility to the NRTIs.
http://cancerres.aacrjournals.org/cgi/reprint/22/11_Part_1/1290.pdfEffect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens said:The results of this study demonstrate that ZDV is useful as a resistance modulator, at least in combination with ABC, effectively reducing the incidence of selection forK65R and L74V. This may increase the likelihood that agents such as ddI, TDF and others affected by these two mutations will remain efficacious in second-line regimens. The relevance of these findings to combinations including NRTIs other than ABC, 3TC and ZDV remains to be elucidated.
The Prediction of Growth-inhibitory Drug Combinations Showing Enhanced Differential Toxicity and Collateral Sensitivity said:The possible application to chemotherapy of factors affecting the regulatory systems of cells has been considered. The extensive coordinate changes in intracellular enzyme concentrations which result from exposure to compounds interfering with the normal regulatory mechanisms suggest the possibility of combination therapy based upon the selective induction of quantitative changes in enzymatic activities. Such approaches would appear to be useful in circumventing two major problems of chemotherapy: finding sufficient metabolic differences between host and parasite to provide targets for selective drug toxicity, and preventing the eventual development of drug resistance.
The Prediction of Growth-inhibitory Drug Combinations Showing Enhanced Differential Toxicity and Collateral Sensitivity said:
It is concluded that a combination of two compounds affecting the same metabolic pathway, one producing feedback inhibition and the other effective through lethal synthesis, will show an enhanced differential toxicity greater than that from either drug alone. Similarly, pairs of compounds in which one member produces enzyme repression and the other is active through lethal synthesis should produce collateral sensitivity and thus prevent the development of drug-resistant populations.